O'Doherty MJ - Search Results

1

Detection of lymphoma in bone marrow by whole-body positron emission tomography.

Carr R, Barrington SF, Madan B, O'Doherty MJ, Saunders CA, van der Walt J, Timothy AR. Carr R, et al. Blood. 1998 May 1;91(9):3340-6. Blood. 1998. PMID: 9558391 Free article.

2

Limitations of PET for imaging lymphoma.

Barrington SF, O'Doherty MJ. Barrington SF, et al. Eur J Nucl Med Mol Imaging. 2003 Jun;30 Suppl 1:S117-27. doi: 10.1007/s00259-003-1169-2. Epub 2003 May 13. Eur J Nucl Med Mol Imaging. 2003. PMID: 12748831 Review.

3

PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study.

Barrington SF, Kirkwood AA, Franceschetto A, Fulham MJ, Roberts TH, Almquist H, Brun E, Hjorthaug K, Viney ZN, Pike LC, Federico M, Luminari S, Radford J, Trotman J, Fosså A, Berkahn L, Molin D, D'Amore F, Sinclair DA, Smith P, O'Doherty MJ, Stevens L, Johnson PW. Barrington SF, et al. Among authors: o doherty mj. Blood. 2016 Mar 24;127(12):1531-8. doi: 10.1182/blood-2015-11-679407. Epub 2016 Jan 8. Blood. 2016. PMID: 26747247 Free article.

4

Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer.

Saunders CA, Dussek JE, O'Doherty MJ, Maisey MN. Saunders CA, et al. Ann Thorac Surg. 1999 Mar;67(3):790-7. doi: 10.1016/s0003-4975(98)01257-0. Ann Thorac Surg. 1999. PMID: 10215230

5

18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas.

Mikhaeel NG, Timothy AR, Hain SF, O'Doherty MJ. Mikhaeel NG, et al. Ann Oncol. 2000;11 Suppl 1:147-50. Ann Oncol. 2000. PMID: 10707798

6

Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse.

Hain SF, O'Doherty MJ, Timothy AR, Leslie MD, Harper PG, Huddart RA. Hain SF, et al. Br J Cancer. 2000 Oct;83(7):863-9. doi: 10.1054/bjoc.2000.1389. Br J Cancer. 2000. PMID: 10970686 Free PMC article. Clinical Trial.

7

[(18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer.

Dhital K, Saunders CA, Seed PT, O'Doherty MJ, Dussek J. Dhital K, et al. Eur J Cardiothorac Surg. 2000 Oct;18(4):425-8. doi: 10.1016/s1010-7940(00)00535-2. Eur J Cardiothorac Surg. 2000. PMID: 11024379

8

2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution.

Partridge S, Timothy A, O'Doherty MJ, Hain SF, Rankin S, Mikhaeel G. Partridge S, et al. Ann Oncol. 2000 Oct;11(10):1273-9. doi: 10.1023/a:1008368330519. Ann Oncol. 2000. PMID: 11106116 Free article.

9

18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CT.

Mikhaeel NG, Timothy AR, O'Doherty MJ, Hain S, Maisey MN. Mikhaeel NG, et al. Leuk Lymphoma. 2000 Nov;39(5-6):543-53. doi: 10.3109/10428190009113384. Leuk Lymphoma. 2000. PMID: 11342337

10

Positron emission tomography in the management of lymphomas.

O'Doherty MJ, Macdonald EA, Barrington SF, Mikhaeel NG, Schey S. O'Doherty MJ, et al. Clin Oncol (R Coll Radiol). 2002 Oct;14(5):415-26. doi: 10.1053/clon.2002.0118. Clin Oncol (R Coll Radiol). 2002. PMID: 12555882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

241 results

Search Page